$REG

Whole Foods, Shake Shack coming to St. Johns County’s fastest-growing community

Regency Centers said it is developing the grocery-anchored open-air shopping center “The Berkeley at Durbin Park” in St. Johns County, Fla., near UF Health Durbin Park. The company plans groundbreaking in Q4 2026 and lists Whole Foods as the anchor, with TJ Maxx, Firebirds Wood Fired Grill, and Shake Shack as tenants. Regency also cites a separate 250,000-sq-ft project, The Village at Seven Pines.

Original reporting
Published Jul 6, 2026, 6:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 6, 2026, 7:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Whole Foods, Shake Shack coming to St. Johns County’s fastest-growing community — source image
Decision brief

The 30-second read

$REGBullishLow
01

Why it matters

The tenant lineup (Whole Foods, TJ Maxx, Firebirds, Shake Shack) and planned Q4 2026 groundbreaking provide incremental pipeline detail, but the lack of financial terms limits near-term trading impact.

02

Market read

A regional development/pipeline update for Regency Centers with named tenants, but no disclosed financials or lease terms.

03

What to watch

Traders may want to verify whether Whole Foods and Shake Shack leases are signed/secured and whether any anchor tenant changes could affect project timing or returns.

Relevance 4/10Novelty 4/10Timing: groundbreaking planned for Q4 2026 (pipeline update)

Background

Regency Centers is a REIT focused on retail properties; this article describes a new grocery-anchored, open-air shopping center in St. Johns County, Florida.

Company-level read

Ticker impact

$REGBullishMedium confidence
Context

Regency Centers is developing The Berkeley at Durbin Park, with Whole Foods and Shake Shack as tenants, and plans Q4 2026 groundbreaking.

Expected impact

Likely modest, if any, near-term impact; more relevant for longer-dated development/pipeline sentiment.

Evidence & confidence

The article discloses a new grocery-anchored center and tenant roster, but provides no capex, lease terms, or financial guidance that would drive a large immediate repricing.

Market effects

Supports the broader theme of grocery-anchored retail development and tenant demand in suburban growth corridors.

Highlights continued investment in the Jacksonville metro (Durbin Park area), which can marginally improve local retail leasing expectations.

Limited; primarily a regional real-estate development update.

Counterpoint

Without disclosed lease economics or project cost, the news may be more marketing than a material earnings driver.

Key entities

  • Regency Centers

    Developer of The Berkeley at Durbin Park, with a stated Q4 2026 groundbreaking plan and named tenants.

  • Whole Foods Market

    Announced as the grocery anchor for the development.

  • Shake Shack

    Announced as part of the tenant lineup for the development.

Related articles

$EVGOMed

EVgo, Regency expand partnership with 400 new EV charging stalls

EVgo and Regency Centers are adding 400 fast-charging stalls at U.S. shopping centers, expanding their 2020 partnership. The new stations will increase Regency's EV charging footprint by over 20%, with locations in major markets. EVgo's chargers can fully charge a vehicle in 15 minutes. The companies aim to meet EV driver demand and support sustainability goals.

$JPMLow

JPMorgan Chase M&A head to retire

Hernan Cristerna, global co-head of M&A at JPMorgan Chase, will retire. He oversaw key deals like InBev's acquisition of Anheuser-Busch and Saudi Aramco's purchase of SABIC. The bank also announced Mark O'Donovan as new head of HR, replacing Robin Leopold. Jamie Dimon is reportedly planning succession while staying for up to three more years.

$NVSHigh

Novartis licenses Abogen mRNA autoimmune drug in $7.8B deal

Novartis licensed Abogen's mRNA therapy ABO2203 for autoimmune diseases in a $7.8B deal, including $575M upfront. Abogen may receive $7.2B more for milestones. Novartis gains exclusive options for Abogen's RNA platform. The deal follows Novartis' recent clinical setbacks, costing $30B in market cap. Investors note the deal's front-loaded structure reduces risk.